Provenance du réseau au premier degré de Amy Pernell Cavers
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 8 | |
| Extinct | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Amy Pernell Cavers via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABIOMED, INC. | Medical Specialties | Compliance Officer | |
| ALZA CORPORATION | Pharmaceuticals: Major | Sales & Marketing | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VERICEL CORPORATION | Pharmaceuticals: Major | General Counsel | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
| BRAINSTORM CELL THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Lipid Sciences, Inc.
 Lipid Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Lipid Sciences, Inc. is a biotechnology company that is engaged in research and development of products and processes intended to treat major medical indications such as cardiovascular disease and viral infections in which lipids or fat components, play a key role. The company is focused on applications of technologies in two main areas: cardiovascular disease, using the HDL Therapy platform and viral infections, using the Viral Immunotherapy platform. HDL Therapy focuses on developing treatments for the reversal of atherosclerosis, which is the leading cause of heart attacks, strokes and peripheral vascular disease. It was formerly known as NZ Corp. The company was founded in 1908 and is headquartered in Pleasanton, CA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director of Finance/CFO | |
| OMEROS CORPORATION | Pharmaceuticals: Major | Investor Relations Contact | |
| ANAPTYSBIO, INC. | Biotechnology | Chairman | |
| MERUELO M | Real Estate Development | Public Communications Contact | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| GELESIS INC | Biotechnology | Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ATRECA, INC. | Biotechnology | Chief Executive Officer | |
Alkahest, Inc.
 Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Biotechnology | Director of Finance/CFO | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| Albany College of Pharmacy & Health Sciences | College/University | Undergraduate Degree | |
| California State University-East Bay | College/University | Masters Business Admin | |
| US Military Academy | College/University | Undergraduate Degree | |
| New York University | College/University | Masters Business Admin | |
| San Jose State University | College/University | Undergraduate Degree | |
| Santa Clara University | College/University | Undergraduate Degree | |
| University of Arizona | College/University | Undergraduate Degree | |
| University of Kansas | College/University | Graduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| The University of California, San Francisco | College/University | Graduate Degree | |
| The United States Army (District of Columbia) | Sovereign | Corporate Officer/Principal | |
Massachusetts Bar Association
 Massachusetts Bar Association Miscellaneous Commercial ServicesCommercial Services The Massachusetts Bar Association is a non-profit organization that serves the legal profession and the public by promoting the administration of justice, legal education, professional excellence, and respect for the law. The MBA is based in Boston, MA. The organization offers various membership advantages, volunteer opportunities, and educational resources such as CLE programs, practicing with professionalism courses, and publications like the ejournal and Lawyers Journal. The MBA also provides advocacy services, public resources, and exclusive benefits to its members such as the Lawyer Referral Service, Insurance Agency, and MBA On Demand. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| RELYPSA INC | Pharmaceuticals: Major | Chief Executive Officer | |
| PHASERX, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| State University of New York at Downstate Medical Center | College/University | Doctorate Degree | |
| Massachusetts School of Law | College/University | Graduate Degree | |
| TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
| ELEVATION ONCOLOGY, INC. | Biotechnology | Founder | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| EQRX, INC. | Pharmaceuticals: Major | Founder | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Chairman | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder |
Statistiques
Internationale
| Etats-Unis | 50 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 16 |
| Commercial Services | 8 |
| Finance | 3 |
| Government | 2 |
Opérationnelle
| Director/Board Member | 28 |
| Corporate Officer/Principal | 24 |
| Independent Dir/Board Member | 12 |
| Director of Finance/CFO | 10 |
| Undergraduate Degree | 10 |
Relations les plus connectées
| Insiders | |
|---|---|
| Robert M. Forrester | 25 |
| John Orwin | 21 |
| Steven Bloom | 10 |
| Michael Byrnes | 10 |
| Erin S. Cox | 6 |
| Sean Flynn | 6 |
| Kirk Taylor | 5 |
| Robert Morgan | 5 |
| Shawn Leland | 5 |
| Timothy Arendt | 3 |
| Linda L. Schock | 2 |
| Brian Sullivan | 1 |
- Bourse
- Insiders
- Amy Pernell Cavers
- Connexions Sociétés
